Tech Company Financing Transactions
Nested Therapeutics Funding Round
On 10/6/2022, Nested Therapeutics raised $90 million in Series A funding from Goldman Sachs, Avidity Partners and Cowen Healthcare Investments.
Transaction Overview
Company Name
Announced On
10/6/2022
Transaction Type
Venture Equity
Amount
$90,000,000
Round
Series A
Investors
Proceeds Purpose
The financing will enable Nested to advance its pipeline programs, attract additional top-tier talent, and further develop its platform that reveals cryptic, or newly uncovered, driver mutations and pockets in high-conviction cancer targets to dramatically expand the reach of precision medicine.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1030 Massachusetts Ave. 410
Cambridge, MA 02138
USA
Cambridge, MA 02138
USA
Phone
Undisclosed
Website
Email Address
Overview
Nested Therapeutics aims to advance precision oncology medicine by finding new driver mutations hiding in plain sight to reach a broader group of patients. Precision medicine approaches are making steady progress in reaching more patients, but the fundamental problem of identifying driver alterations hiding in plain sight and uncovering novel targeting mechanisms to tap into a vast array of targets remains a significant bottleneck.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Darrin Miles
Chief Scientific Officer
Klaus Hoeflich
Executive Vice President
Yongxin Han
Browse more venture capital transactions:
Prev: 10/6/2022: CrowdSec venture capital transaction
Next: 10/6/2022: The Rounds venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on every notable VC transaction. VC investment data records reported here are derived from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs